TPIDB > 臨床試驗主持人
臨床試驗主持人
長庚醫療財團法人台北長庚紀念醫院
風濕免疫科
更新時間：2023-09-19
蔡秉翰Tsai, Ping-Han
- 計畫主持人
- 執行臨床試驗年資 12 年 9 個月
-
s001033@gmail.com
-
s001033@gmail.com
發表文獻
6筆
1
Tsai PH, Chang PY, Cheng CH, Yu KH. Diagnostic performance of tests for anti-cyclic citrullinated peptides and rheumatoid factor in rheumatoid arthritis. Formosan Journal of Rheumatology 2014;28:10-17.
2
Yu KH, Chan TM, Tsai PH, et al. Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease. Medicine 2015;94:e1707.
3
Tsai PH, Yu KH, Chou IJ, Luo SF, Tseng WY, Huang LH, Kuo CF: Risk of autism spectrum disorder in children born to mothers with systemic lupus erythematosus and rheumatoid arthritis in Taiwan. Joint, bone, spine : revue du rhumatisme 2018, 85(5):599-603.
4
Tsai PH, Jang SS, Liou LB: Septicaemia is associated with increased disease activity and mortality in systemic lupus erythematosus: a retrospective analysis from Taiwan. Lupus 2020, 29(2):191-198.
5
Liou L-b, Fang Y-F, Tan CF, Lai J-H, Jang S-s, Tsai P-H, Yeh T-c: A new laboratory surrogate (Monocyte Chemotactic Protein-1) for Disease Activity Score28: a favourable indicator for remission in rheumatoid arthritis. Scientific Reports, 2020. 10(1): p. 8238.
6
Tsai P-H, Kuo C-F, See L-C, Li P-R, Chen J-S, Tseng W-Y. "Stroke Risk in Patients with Gout: A Nationwide Retrospective Cohort Study in Taiwan." Journal of Clinical Medicine 11, no. 13 (2022): 3779.
